A medicinal chemist, an inventor on 200 U.S. patents, and the author of over 95 journal articles, CHE-1374 has broad experience in patent strategies. He consults extensively in preparing, expanding, evaluating, interpreting, and defending chemical, pharmaceutical, and medicinal patents. He has been a vice president and director of research for several pharmaceutical companies and is currently the president and CEO of a chemical and pharmaceutical consulting firm, which he founded in 1986. He has provided consulting services to many U.S. and foreign companies, to universities, and to patent law firms. He has also been an arbitrator for the American Arbitration Association. Most of CHE-1374s scientific career has been focused upon the design and synthesis of entirely new types of molecular structures for the treatment of diseases. He discovered the nifedipine class of calcium channel blockers, widely prescribed for the treatment of angi


Ph.D., Organic Chemistry, Columbia University

Request this expert

Your request has been submitted successfully.

building Own or work here? Claim Now! Claim Now!

Claim This Listing